Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility - PubMed
6 hours ago
- #Intravenous Supplements
- #Evidence Review
- #Longevity Therapy
- Intravenous longevity therapy uses high doses of supplements to target aging processes, but evidence is limited.
- The therapy aims to achieve high plasma levels by bypassing gastrointestinal absorption.
- Preclinical and small clinical studies show temporary benefits like reduced oxidative stress and improved fatigue.
- However, studies lack focus on healthy aging populations and validated aging biomarkers.
- Challenges include inconsistent protocols, risks, and insufficient placebo-controlled trials.
- It should be considered experimental until more rigorous trials prove long-term efficacy and safety.